- Christopher A. Viehbacher | Biogen
Christopher A Viehbacher joined Biogen as President and Chief Executive Officer and a member of the Board of Directors in November 2022 Viehbacher has extensive international experience in both large pharmaceutical companies and entrepreneurial biotech companies and has a passion for advancing science for the benefit of patients and public
- Chris Viehbacher - Wikipedia
He joined Biogen as President and Chief Executive Officer and member of the Board of Directors in November 2022 [6]
- Biogen CEO sees no burning need for more acquisitions
"The view out there in the analyst community is that the future of Biogen depends on the next deal that we do and that's not a view that we share inside Biogen," CEO Chris Viehbacher told
- Our CEO, Chris Viehbacher, is sharing Biogen’s strategy . . . - LinkedIn
Our CEO, Chris Viehbacher, is sharing Biogen’s strategy and key growth drivers at the 43rd Annual J P Morgan Healthcare Conference Join the webcast live on January 14, at 9:45am PT 12:45pm ET
- Christopher A. Viehbacher - BIIB | Biogen Inc. - Wall Street Journal
Christopher A Viehbacher is the founder of Boston Pharmaceuticals, Inc Current jobs include President, Chief Executive Officer Director at Biogen, Inc since 2022, Chairman at ERT Operating Co
- Biogen CEO Christopher Viehbacher at LABEST
At LABEST 2024, Belldegrun introduced keynote speaker Christopher Viehbacher, the current President and CEO of Biogen, with equal parts admiration, personal reflection, and deep understanding of the stakes in modern medicine
- No radical left turns: Biogens new CEO outlines strategy, key . . .
Source: Getty Images Christopher Viehbacher, the 35-year pharma vet and former Sanofi CEO appointed president CEO of Biogen in November, joins the company at a crossroads
- Leadership | Biogen
Meet our executive leadership teamHead of Corporate Affairs, Chief Communications Officer
|